Global Smart Pills Market size to record 11.4% CAGR through

Pune, India, Oct. 19, 2022 (GLOBE NEWSWIRE) — MarketStudyReport recently added report, global smart pills market is anticipated to record a CAGR of 11.4% during 2022-2028.

Following that, the report is separated into four categories: application ambit, disease indication, target area, and end-user scope. The primary geographic regions of the industry are then discussed, along with their growth rates and revenue contributions. Finally, it offers a list of the key participants in the market along with several suggestions and techniques for building a strong presence in the commercial world.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/5517006/

The industry growth is primarily driven by increasing elderly population and the rising incidence of lifestyle-related diseases like obesity, stomach ulcers, & gastroesophageal reflux disease (GERD).

Furthermore, prevalence of chronic diseases including cancer, diabetes, etc., as well as rising R&D expenditures for the creation of the smart pill are spurring market expansion.

Notably, patients suffering specific lifestyle disorders favor minimally invasive methods, which is expected to present a big opportunity for the development of smart medicines, thereby impelling the industry outlook in the coming years.

Market segment overview:

Based on application ambit, worldwide smart pills market is divided into drug delivery, patient monitoring, capsule endoscopy, and others. Among these, the capsule endoscopy segment is gaining traction at present, and is estimated to showcase notable expansion during the analysis period.

In terms of disease indication, the industry is branched into small bowel tumors, digestive tract diseases, colon diseases, esophageal diseases, and others. Out of which, the esophageal diseases segment is poised to log significant growth during the forecast period.

On the basis of target area, the market is categorized into stomach, small intestine,…